CN Patent
CN118453872A — 治疗下尿路尿道上皮癌的方法
Assigned to Liris Biomedical Inc · Expires 2024-08-09 · 2y expired
What this patent protects
本发明提供了与用抗代谢药(例如吉西他滨)治疗下尿路尿道上皮癌相关的方法、装置和试剂盒。在一些方面,所述方法、装置和试剂盒涉及用抗代谢药(例如吉西他滨)和免疫调节剂治疗下尿路尿道上皮癌。
USPTO Abstract
本发明提供了与用抗代谢药(例如吉西他滨)治疗下尿路尿道上皮癌相关的方法、装置和试剂盒。在一些方面,所述方法、装置和试剂盒涉及用抗代谢药(例如吉西他滨)和免疫调节剂治疗下尿路尿道上皮癌。
Drugs covered by this patent
- Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.